Nuveen Asset Management’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.19M | Hold |
33,193
| – | – | ﹤0.01% | 2637 |
|
|
2024
Q3 | $1.26M | Hold |
33,193
| – | – | ﹤0.01% | 2654 |
|
|
2024
Q2 | $1.5M | Sell |
33,193
-14,111
| -30% | -$638K | ﹤0.01% | 2521 |
|
|
2024
Q1 | $2.29M | Buy |
47,304
+12,035
| +34% | +$584K | ﹤0.01% | 2338 |
|
|
2023
Q4 | $1.89M | Buy |
35,269
+2,206
| +7% | +$118K | ﹤0.01% | 2435 |
|
|
2023
Q3 | $1.94M | Sell |
33,063
-273
| -0.8% | -$16K | ﹤0.01% | 2304 |
|
|
2023
Q2 | $2.1M | Buy |
33,336
+273
| +0.8% | +$17.2K | ﹤0.01% | 2314 |
|
|
2023
Q1 | $2.08M | Sell |
33,063
-319
| -1% | -$20.1K | ﹤0.01% | 2314 |
|
|
2022
Q4 | $1.78M | Sell |
33,382
-2,999
| -8% | -$160K | ﹤0.01% | 2443 |
|
|
2022
Q3 | $2.04M | Sell |
36,381
-153
| -0.4% | -$8.58K | ﹤0.01% | 2396 |
|
|
2022
Q2 | $2.64M | Sell |
36,534
-75,222
| -67% | -$5.44M | ﹤0.01% | 2297 |
|
|
2022
Q1 | $9.01M | Sell |
111,756
-26,341
| -19% | -$2.12M | ﹤0.01% | 1717 |
|
|
2021
Q4 | $13.9M | Sell |
138,097
-17,639
| -11% | -$1.78M | ﹤0.01% | 1475 |
|
|
2021
Q3 | $13.8M | Sell |
155,736
-5,396
| -3% | -$480K | ﹤0.01% | 1542 |
|
|
2021
Q2 | $16.5M | Sell |
161,132
-10,667
| -6% | -$1.09M | ﹤0.01% | 1515 |
|
|
2021
Q1 | $16.8M | Buy |
171,799
+26,389
| +18% | +$2.58M | 0.01% | 1452 |
|
|
2020
Q4 | $11.2M | Buy |
145,410
+9,060
| +7% | +$699K | ﹤0.01% | 1640 |
|
|
2020
Q3 | $10M | Buy |
136,350
+87,394
| +179% | +$6.44M | ﹤0.01% | 1521 |
|
|
2020
Q2 | $3.6M | Sell |
48,956
-3,360
| -6% | -$247K | ﹤0.01% | 2074 |
|
|
2020
Q1 | $3.02M | Sell |
52,316
-120,677
| -70% | -$6.97M | ﹤0.01% | 1982 |
|
|
2019
Q4 | $13.6M | Sell |
172,993
-54,209
| -24% | -$4.26M | 0.01% | 1401 |
|
|
2019
Q3 | $15.5M | Buy |
227,202
+7,413
| +3% | +$507K | 0.01% | 1293 |
|
|
2019
Q2 | $17.5M | Buy |
+219,789
| New | +$17.5M | 0.01% | 1238 |
|
|
2017
Q3 | – | Sell |
-13,662
| Closed | -$876K | – | 1141 |
|
|
2017
Q2 | $876K | Buy |
+13,662
| New | +$876K | 0.01% | 782 |
|